WA
Waters Corp
WAT·NYSEMilford MAFounded 19588,000 employees
Large CapbiotechPublicOncology
Platform: LC MS Instruments
Market Cap
$20B
All Drugs
6
Clinical Trials
6
Failed / Terminated
2
FDA Approved
2
Stock Price & Catalysts (WAT)
Loading WAT stock data...
Drug Pipeline (6 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| WAT-3378 | WAT-3378 | Phase 2 | 1 | LAG-3 | CKD | ||
| Voxatenlimab | WAT-5274 | Approved | 1 | PI3Kα | GANASH | ||
| Miricilimab | WAT-9813 | Phase 2/3 | 1 | IL-17A | ALL | ||
| Sotozumab | WAT-1861 | Approved | 1 | PRMT5 | HCC | ||
| WAT-1779 | WAT-1779 | Phase 1 | 1 | KRASG12D | PVMeso | ||
| WAT-2618 | WAT-2618 | Preclinical | 1 | IL-17A | MDSWM |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)